T2 Biosystems to Report Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021
February 23 2021 - 8:00AM
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid
detection of sepsis-causing pathogens, announced today that it will
report financial results for the fourth quarter and full year 2020
after market close on Thursday, March 4, 2021. Company
management will host a corresponding conference call beginning
at 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do
so by accessing a live and archived webcast of the event
at www.t2biosystems.com, on the Investors page in the Events
& Presentations section. The call will also be available by
dialing 877-407-9208 (U.S.) or 201-493-6784 (International) five to
ten minutes prior to the start time.
About T2 Biosystems:T2 Biosystems, a
leader in the rapid detection of sepsis-causing pathogens, is
dedicated to improving patient care and reducing the cost of care
by helping clinicians effectively treat patients faster than ever
before. T2 Biosystems’ products include the T2Dx® Instrument,
T2Candida® Panel, the T2Bacteria® Panel, the T2Resistance™ Panel,
and the T2SARS-CoV-2™ Panel and are powered by the proprietary T2
Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active
pipeline of future products, including the T2Cauris™ Panel, and
T2Lyme™ Panel, as well as additional products for the detection of
bacterial and fungal pathogens and associated antimicrobial
resistance markers, and biothreat pathogens.
Media Contact:Gina Kent, Vault
Communicationsgkent@vaultcommunications.com610-455-2763
Investor Contact:Philip Trip Taylor, Gilmartin
Groupphilip@gilmartinIR.com415-937-5406
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Aug 2024 to Sep 2024
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Sep 2023 to Sep 2024